Biotechnology Stocks II Performance Guide: Astria Therapeutics, Inc. (ATXS)
ATXS has no dividends.
Table and Chart of ATXS Performance
See what a $1,000 investment in ATXS is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| ATXS Returns | |
|---|---|
| Start Date | Jul-31-2015 |
| Start Price | $780.00 |
| End Date | May-16-2024 |
| End Price | $9.43 |
| # Prices | 107 |
| Min Date | Jun-30-2022 |
| Min Price | $3.00 |
| Max Date | Jul-31-2015 |
| Max Price | $780.00 |
| Total Return | -98.79% |
| Annualized Return | -39.05% |
| Current Value of $1,000 Purchase | $12 |
| Number Returns | 5,671 |
| Average Return | -56.41% |
| Number Profitable Returns | 680 |
| Percent Profitable Returns | 11.99% |
| Number Unprofitable Returns | 4,991 |
| Percent Unprofitable Returns | 88.01% |
| Profitable to Unprofitable Returns Ratio | 0.14 |
| ATXS Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $509,044,000 |
| Beta | 0.810 | Price to Sales |
| Earnings per Share | $-2.4000 |
| PE Ratio | None |
| PE to Growth Ratio | None |
| Price to Book | 4.016 |
| PRICE DATA | |
| 52 Week High | $16.9 |
| 52 Week Low | $4.26 |
| Analyst Target Price | $24.29 |
| 50-Day Moving Average | $11.88 |
| 200-Day Moving Average | $9.04 |
| FINANCIAL DATA | |
| Revenue per Share | $0 |
| Revenue | $0 |
| Profit Margin | 0% |
| Return on Equity | -28.2% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
ATXS Compare Returns with S&P 500
ATXS Trendline Chart
ATXS Moving Average Chart
ATXS Stock Return Map - See Patterns of Gains and Losses
ATXS Stock Returns/Purchase Dates